Ventures Bonesupport 2. september 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Acacia Pharma 16. august 2019 Acacia Pharma Group PLC – Acacia Pharma Group plc – Issue of Equity on Exercise of Options Acacia Pharma 12. august 2019 Acacia Pharma Group PLC – Acacia Pharma Group plc: Notice of Interim Results Bonesupport 25. juli 2019 BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report Acacia Pharma 18. juli 2019 Acacia Pharma Group PLC – Acacia Pharma Founder Dr. Julian Gilbert steps down – Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession Bonesupport 18. juli 2019 BONESUPPORT HOLDING AB (publ) – Q2 2019 Interim Report – invitation to conference call and webcast scPharmaceuticals 16. juli 2019 scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX® Acacia Pharma 12. juli 2019 Acacia Pharma Group PLC – Editorial on Positive Data for BARHEMSYS® Treatment of Post-Operative Nausea & Vomiting (PONV) Published in Anesthesia & Analgesia Acacia Pharma 8. juli 2019 Acacia Pharma Group PLC – Acacia Pharma Plans to Resubmit the BARHEMSYS® NDA in Q3 2019 scPharmaceuticals 3. juli 2019 scPharmaceuticals Announces FUROSCIX® NDA Resubmission Sideinddeling Første side « Første Forrige side ‹‹ … Side 6 Side 7 Side 8 Side 9 Nuværende side 10 Side 11 Side 12 Side 13 Side 14 … Næste side ›› Sidste side Sidste »
